comparemela.com

Page 3 - Drug Treatment Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Diagnosis Creep : Are Some AF Patients Overtreated?

Earlier detection or classification of medical conditions is leading to patients becoming eligible for treatments sooner in the disease course; use of anticoagulants in AF patients is one example.

Mintu turakhiaStanford universityUniversity of liverpoolNetwork open onRhythm technologies incNational cardiovascular data registry practice innovationClinical excellenceMedscape cardiologyGregory lipAtrial fibrillationF atrial fibrillationDrug treatment safetyAnticoagulation therapyIncreased blood pressureDiagnostics and medical deviceIagnostics and medical devices

Docs Weigh In on Insurance Coverage for Obesity Medications

Supply and demand issues and rising costs drove some insurers to cut coverage.

Ann arborUnited statesAndrew kraftsonScott kahanLauren oshmanUniversity of texasObesity medicine associationUniversity of michiganGeorge washington universityDrug administrationNational centerDrug shortages listPrime therapeuticsPlan detailsMedscape medicalMichigan collaborative

Topical Botanical Drug Coacillium Curbs Childhood Alopecia

Greater improvement in Severity of Alopecia Tool (SALT) scores at 24 weeks were seen with coacillium vs placebo, which lasted after treatment stopped.

New yorkUnited statesEmma guttman yasskyPaola pasqualiP ulrike blume peytaviEuropean academy of dermatologyDrug administrationEuropean medicines agencyIcahn school of medicine at mount sinaiDepartment of dermatologyEuropean academyAlopecia toolPius hospital de vallsEuropean medicinesIcahn schoolMount sinai

FDA Warns Online Vendors to Stop Selling Unapproved Weight-Loss Drugs

The FDA on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide.

Patrick wingroveEli lilly mounjaroDavid gregorioDrug administrationNovo nordiskGorilla healingEli lillyWeight managementWeight lossGlp 1 receptor agonistsGlucagon like peptide 1 receptor agonistsPatient safetyDrug treatment safetyDrug safetyTreatment safetyUs food and drug administration

FDA Gives Ozempic Two Drug Safety–Related Label Changes

The US Food and Drug Administration made two drug safety–related changes to the label for Ozempic, the weight-loss formulation of the GLP-1 receptor agonist semaglutide.

Wegovy novo nordiskNovo nordiskDrug administrationIleus episodes after approvalDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesPatient safetyGlp 1 receptor agonistsGlucagon like peptide 1 receptor agonistsDrug treatment safetyWeight managementWeight lossDrug interactionsUs food and drug administrationNited states food and drug administration

vimarsana © 2020. All Rights Reserved.